UnitedHealth stock returns 14.89% annually over 15 years

0 min read | Published on 17 Jul 2026, 03:08 AM |Updated on 17 Jul 2026, 03:08 AM

Reviewed by

Radhika SScanX News Team

Key Highlights

UnitedHealth Group delivered a 14.89% average annual return over the last 15 years, outperforming the market by 2.75%. A $1000 investment from 15 years ago is now worth $8,118.50. The company's current market capitalization stands at $385.96 billion.

*this image is generated using AI for illustrative purposes only.

UnitedHealth Group has outperformed the market over the past 15 years by 2.75% on an annualized basis, producing an average annual return of 14.89%. The company currently holds a market capitalization of $385.96 billion. This performance highlights the impact of compounded returns on long-term investment growth.

Investment Growth Analysis

An investor who purchased $1000 of UnitedHealth Group stock 15 years ago would see a significant increase in value today. Based on a current price of $425.00, that initial investment has grown to $8,118.50.

Key Financial Metrics

Metric	Value
Average Annual Return	14.89%
Market Outperformance	2.75%
Current Market Capitalization	$385.96 billion
Current Share Price	$425.00

The data illustrates how compounded returns can substantially increase cash growth over an extended period. The consistent outperformance relative to the market underscores the stock's long-term value appreciation for shareholders.

Can UnitedHealth Group maintain its 14.89% average annual return over the next decade given current market conditions?

How might regulatory changes in the healthcare sector impact UnitedHealth's future growth trajectory?

What are the key risks that could disrupt the company's compounded returns moving forward?

UnitedHealth shares fall ahead of Q2 earnings report

1 min read | Published on 13 Jul 2026, 12:22 AM |Updated on 15 Jul 2026, 07:06 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

UnitedHealth Group Incorporated shares declined 2.20% to $415.85 ahead of its Q2 earnings report on Thursday. Analysts project EPS of $4.85 and revenue of $110.77 billion, following a streak of beating estimates. Recent analyst actions include target raises by TD Cowen, Truist Securities, and Keybanc.

*this image is generated using AI for illustrative purposes only.

UnitedHealth Group Incorporated shares are in focus as the company prepares to report its second-quarter earnings before the market opens on Thursday. The stock is currently experiencing downward pressure, trading 2.20% lower at $415.85 at the time of publication. Investors are awaiting quarterly results, with analysts anticipating earnings per share of $4.85 and revenue of $110.77 billion. The company has beaten EPS estimates in three consecutive quarters, including the most recent period where it reported EPS of $7.23 against estimates of $6.56 and revenue of $111.72 billion against estimates of $109.57 billion.

Analyst Consensus and Recent Actions

The stock carries a Buy rating with an average price target of $432.63. Several analysts have recently adjusted their price targets ahead of the earnings release. TD Cowen maintained a Hold rating and raised its target to $430.00. Truist Securities maintained a Buy rating and raised its target to $480.00. Keybanc maintained an Overweight rating and raised its target to $475.00.

Key Metrics to Watch

Investors should monitor Medicare Advantage membership trends and pricing commentary related to the recent payment hike, which serves as a macro tailwind for the sector. Additionally, growth in Optum's services and pharmacy benefit businesses will be scrutinized to offset any potential flat-to-down consolidated revenue.